Tag: GlobalData
Vaccines with efficacy against Omicron variants will gain competitive advantage in...
According to GlobalData’s Pharma Intelligence Center, there are currently 19 COVID-19 vaccines in clinical development in China, with only 3 candidates in Phase III trials
500% surge in discussions around Ebola on social media: GlobalData
The recent spike in social media conversations was noticed in the second week of October, following the confirmation of Ebola cases in Kampala
Japan’s homegrown COVID-19 mRNA vaccine needs superior safety & efficacy data...
In 2021, leading mRNA vaccines, Comirnaty and Spikevax, generated combined sales of more than $54 billion globally and are expected to generate similar or greater sales in 2022
AstraZeneca likely to see substantial Evusheld uptake in Japan, says GlobalData
The government’s decision to limit the drug’s supply to only COVID-19 prevention will still likely encourage its uptake, says GlobalData, a leading data and analytics company
Growing investment in biotech startups likely to make CAR-T therapies affordable...
Increased investments likely to boost the research and production capabilities and eventually makes the therapies affordable to those in need, says GlobalData, a leading data and analytics company.
Covovax to help Serum Institute to enter adolescents COVID-19 vaccine market:...
According to GlobalData’s Pharma Intelligence Center, Covovax is India's fourth COVID-19 vaccine approved for adolescents aged 12 to 18 years
China focuses on next-generation intranasal COVID-19 vaccines amid rising mutant strains
Several pharmaceutical companies across the world have started working on the inhaled vaccine formulations and China is also developing next-generation intranasal COVID-19 vaccines, says GlobalData....................
Approval in India paves way for Bharat Biotech to take Covaxin...
Recently, Bharat Biotech has applied for regulatory approval to conduct clinical trials in Bangladesh and has applied for EUA in the Philippines.....................
Chinese biotech revolution to have highest impact globally in 2019, says...
The government-supported Chinese biotech revolution will bring forth many Chinese drug developers to compete with well-established multinational drug companies...............
Gene-editing a significant leap forward but only if used ethically
In the backdrop of the claims made by Chinese scientists, He Jiankui that he has edited the human genome embryo, the experts have pointed out that it has not been proven to be safe, and acceptable ethical guidelines have yet to be fully drafted or agreed upon...…………….